Perry Mark Elliott
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Viral Infections and Immunology Research
- Cardiac electrophysiology and arrhythmias
- Heart Failure Treatment and Management
- Cardiac Arrhythmias and Treatments
- Physiology top 0.2%
Papers in
-
- Cardiomyopathy and Myosin Studies 327
- Cardiovascular Effects of Exercise 147
- Cardiovascular Function and Risk Factors 70
- Viral Infections and Immunology Research 57
- Cardiac pacing and defibrillation studies 45
- Cardiac electrophysiology and arrhythmias 34
- Physiology 66
- Lysosomal Storage Disorders Research 55
- Co-authors
- William John McKenna (162 shared papers)Juan Ramón Gimeno (32 shared papers)Lorenzo Monserrat (21 shared papers)James Moon (51 shared papers)Claudio Rapezzi (21 shared papers)Constantinos O’Mahony (34 shared papers)Niall Mahon (11 shared papers)Atul B Mehta (21 shared papers)
- Journals
- European Heart Journal (95 papers)Heart (55 papers)Journal of the American College of Cardiology (55 papers)Circulation (22 papers)Journal of Cardiovascular Magnetic Resonance (17 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Perry Mark Elliott
670 papers receiving 70.9k citations
Perry Mark Elliott's Hit Papers
Peers
Comparison fields: 5 of 199
- Cardiology and Cardiovascular Medicine 47.9k
- Physiology 5.9k
- Radiology, Nuclear Medicine and Imaging 4.2k
- Nephrology 1.3k
- Epidemiology 5.5k
Countries citing papers authored by Perry Mark Elliott
This map shows the geographic impact of Perry Mark Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Mark Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Mark Elliott more than expected).
Fields of papers citing papers by Perry Mark Elliott
This network shows the impact of papers produced by Perry Mark Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Mark Elliott. The network helps show where Perry Mark Elliott may publish in the future.
Co-authors
The 25 scholars most cited alongside Perry Mark Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 703 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Hit paper breakdown → | 2012 | 5772 |
| 2 | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Hit paper breakdown → | 2015 | 3009 |
| 3 | ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 Hit paper breakdown → | 2008 | 2952 |
| 4 | Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Hit paper breakdown → | 2013 | 2600 |
| 5 | ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 Hit paper breakdown → | 2012 | 2285 |
| 6 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Hit paper breakdown → | 2008 | 2243 |
| 7 | Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases Hit paper breakdown → | 2007 | 2205 |
| 8 | Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy Hit paper breakdown → | 2018 | 1990 |
| 9 | 2023 ESC Guidelines for the management of cardiomyopathies Hit paper breakdown → | 2023 | 1451 |
| 10 | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Hit paper breakdown → | 2015 | 1421 |
| 11 | 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease Hit paper breakdown → | 2020 | 1288 |
| 12 | 2018 ESC Guidelines for the diagnosis and management of syncope Hit paper breakdown → | 2018 | 1241 |
| 13 | A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) Hit paper breakdown → | 2013 | 911 |
| 14 | 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Hit paper breakdown → | 2013 | 884 |
| 15 | Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases Hit paper breakdown → | 2016 | 849 |
| 16 | Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 845 |
| 17 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary Hit paper breakdown → | 2020 | 831 |
| 18 | European Society of Cardiology: cardiovascular disease statistics 2021 Hit paper breakdown → | 2021 | 785 |
| 19 | Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis Hit paper breakdown → | 2010 | 754 |
| 20 | Sudden death in hypertrophic cardiomyopathy: identification of high risk patients Hit paper breakdown → | 2000 | 752 |
About Perry Mark Elliott
Perry Mark Elliott is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Epidemiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 703 papers that have together received 73.8k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (327 papers), Cardiovascular Effects of Exercise (147 papers), Cardiovascular Function and Risk Factors (70 papers), Viral Infections and Immunology Research (57 papers), Lysosomal Storage Disorders Research (55 papers), Cardiac pacing and defibrillation studies (45 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (35 papers) and Cardiac electrophysiology and arrhythmias (34 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (47.9k citations), Physiology (5.9k citations), Radiology, Nuclear Medicine and Imaging (4.2k citations), Nephrology (1.3k citations) and Epidemiology (5.5k citations). Perry Mark Elliott has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include William John McKenna, Juan Ramón Gimeno, Lorenzo Monserrat, James Moon, Claudio Rapezzi, Constantinos O’Mahony, Niall Mahon, Atul B Mehta, Petros Syrris and Aleš Linhart. Their work appears in journals such as European Heart Journal, Heart, Journal of the American College of Cardiology, Circulation and Journal of Cardiovascular Magnetic Resonance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.